Archives

  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2025-09
  • 2025-03
  • 2025-02
  • 2025-01
  • 2024-12
  • 2024-11
  • 2024-10
  • 2024-09
  • 2024-08
  • 2024-07
  • 2024-06
  • 2024-05
  • 2024-04
  • 2024-03
  • 2024-02
  • 2024-01
  • 2023-12
  • 2023-11
  • 2023-10
  • 2023-09
  • 2023-08
  • 2023-07
  • 2023-06
  • 2023-05
  • 2023-04
  • 2023-03
  • 2023-02
  • 2023-01
  • 2022-12
  • 2022-11
  • 2022-10
  • 2022-09
  • 2022-08
  • 2022-07
  • 2022-06
  • 2022-05
  • 2022-04
  • 2022-03
  • 2022-02
  • 2022-01
  • 2021-12
  • 2021-11
  • 2021-10
  • 2021-09
  • 2021-08
  • 2021-07
  • 2021-06
  • 2021-05
  • 2021-04
  • 2021-03
  • 2021-02
  • 2021-01
  • 2020-12
  • 2020-11
  • 2020-10
  • 2020-09
  • 2020-08
  • 2020-07
  • 2020-06
  • 2020-05
  • 2020-04
  • 2020-03
  • 2020-02
  • 2020-01
  • 2019-12
  • 2019-11
  • 2019-10
  • 2019-09
  • 2019-08
  • 2019-07
  • 2019-06
  • 2019-05
  • 2019-04
  • 2018-11
  • 2018-10
  • 2018-07
  • Finally it is recently reported that respiratory supercomple

    2018-11-01

    Finally, it is recently reported that respiratory supercomplex assemblies increase in response to exercise (Greggio et al., 2017). Our drug MA-5 is an alternative exercise mimetics to increase the formation of ATP synthase dimer and supercomplex formation chemically, important on health and performance. It will be helpful not only mitochondrial disease but also other mitochondria-related metabolic disorders such as diabetes, diabetic nephropathy, cardiomyopathy, longevity etc. The following are the supplementary data related to this article.
    Funding Sources This works was supported in part by National grant-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (26670070), Translational Research Network Program (B20) and research support from the Dainippon-Sumitomo Pharm. and Daiichi-Sankyo Pharm. T.H., F.N. and H.-J.H are hired by a collaborative research grant of DSP.
    Conflicts of Interest
    Author Contributions
    Acknowledgments
    Introduction DNA repair provides a major protection against cancer, and germline DNA repair defects in inherited syndromes confer a significant cancer predisposition. DNA replication errors are a major source of mutations, and early-onset colorectal and other cancers are associated with germline mutations in DNA mismatch repair (MMR) genes (Lynch et al., 2015) or in the proofreading exonuclease domains of DNA polymerases POLE and POLD1 (Palles et al., 2013). In a distinct mutational mechanism, endogenously or exogenously generated reactive oxygen species (ROS) induce pre-mutagenic DNA lesions. Most ROS-induced base damage is repaired by base excision repair (BER) initiated by DNA glycosylases. 8-Oxoguanine (8-oxoG), one of the most common oxidative DNA lesions can mispair with amount of during DNA replication to generate G:C>T:A transversion mutations. 8-oxoG-induced mutagenesis is prevented by the cooperative action of the DNA glycosylases encoded by the OGG1 and MUTYH genes. OGG1 removes 8-oxoG from 8-oxoG:C pairs and MUTYH scans the newly-synthesized daughter strand to locate and remove incorporated adenine mispaired with 8-oxoG (Mazzei et al., 2013; Markkanen et al., 2013; Tsuzuki et al., 2007). A hydrolase encoded by the MTH1 gene provides a third level of protection against oxidative mutagenesis by degrading 8-oxodGTP to prevent the incorporation of 8-oxodGMP into DNA (Mo et al., 1992). Inactivation of any of these genes increases steady-state DNA 8-oxoG levels and confers a mutator phenotype (Klungland et al., 1999; Tsuzuki et al., 2001; Hirano et al., 2003). To date, no human disease has been associated with defective OGG1 or MTH1 activities. In contrast, germline biallelic MUTYH mutations underlie MUTYH-associated polyposis (MAP), a recessively heritable colorectal polyposis with a predisposition to colorectal cancer (CRC) (Al-Tassan et al., 2002; Sieber et al., 2003). CRCs in MAP patients bear distinctive somatic G:C>T:A transversions in the APC gene (Al-Tassan et al., 2002; Sieber et al., 2003; Jones et al., 2002). The relationship between defective repair of oxidized DNA and CRC susceptibility was strengthened by the recent report that germline mutations in NTHL1, encoding a DNA glycosylase involved in the BER of oxidized pyrimidines are associated with a polyposis clinically similar to MAP (Weren et al., 2015). Thus, two repair pathways counteract CRC susceptibility by acting at replication to process mismatches containing oxidized DNA bases. Mutational signatures in cancer genomes provide indications of the mechanisms underlying neoplastic transformation (Alexandrov, 2015; Alexandrov et al., 2013a,b, 2015; Helleday et al., 2014). Thus, CRC from MAP patients offer the unique opportunity to identify a mutational fingerprint of persistent 8-oxoG:A mismatches. Here, we report that whole-exome DNA sequencing identifies a distinct mutational signature of G:C>T:A transversions in MAP CRC. The mutational signature is reflected in the specific pattern of oncogenes/tumour suppressors involved in colorectal carcinogenesis and associated with inactive MUTYH. Our findings also indicate the possible involvement of DNA oxidation-related mutations in other types of human cancer as the MUTYH mutational fingerprint is present in cancers of other organs.